文献速递肺栓塞与肺血管病

肺栓塞疑诊三种诊断策略比较:SPECT V/Q、CTPA与平面V/Q的非劣效随机试验

Comparison of three diagnostic strategies for suspicion of pulmonary embolism: planar ventilation/perfusion scan, CT pulmonary angiography and single-photon emission CT ventilation/perfusion scan - a multicentre, non-inferiority randomised controlled trial
RSS 订阅 · PubMed 高证据 · 肺栓塞 · 2026-04-02

多中心非劣效随机试验将603例临床疑诊急性肺栓塞患者按2:1:1分配至SPECT V/Q、CTPA与平面V/Q诊断策略。SPECT V/Q组与CTPA及平面V/Q联合组在阴性未治疗患者3个月VTE风险差为0.0%(95%CI -1.2–1.3%),但试验因招募缓慢与经费限制提前终止,未证明非劣效。

要点

  • SPECT V/Q策略阴性未治疗者3个月VTE风险0.5%(1/221),联合对照组0.0%(0/107)。
  • 组间3个月VTE风险差0.0%(95%CI -1.2–1.3%),未达预设1%非劣效界值结论。
  • 试验提前终止,结果提示SPECT V/Q策略下3个月VTE风险低,或可作临床替代选择。

核心结论

  • 试验提前终止后,未证明SPECT V/Q策略相对参考标准在肺栓塞诊断中非劣效。
  • 结果提示采用SPECT V/Q诊断策略管理的患者3个月VTE风险较低。
  • 在需胸部影像的临床疑诊急性肺栓塞患者中,SPECT V/Q算法可能是临床实践中可靠的替代方案。

研究设计与样本

  • 多中心、非劣效随机对照试验,按2:1:1分配至SPECT V/Q、CTPA与平面V/Q诊断策略。
  • 2017年7月至2024年10月共随机603例患者,2024年10月因招募缓慢与经费限制提前终止。
  • 主要终点为阴性检查后未治疗患者3个月VTE风险,非劣效界值为绝对差1%。

主要发现

  • 肺栓塞诊断率:SPECT V/Q组61/303(20.1%),CTPA组31/150(20.7%),平面V/Q组24/150(16.0%)。
  • 阴性未治疗者3个月VTE风险:SPECT V/Q组0.5%(1/221),CTPA组0.0%(0/107),平面V/Q组0.8%(1/118)。
  • SPECT V/Q组与联合对照组3个月VTE风险差为0.0%(95%CI -1.2–1.3%)。

关键数值与推荐

  • 非劣效界值定义为3个月VTE风险绝对差1%。
  • 主要终点为阴性检查后未治疗患者3个月VTE风险。
  • 次要结局包括肺栓塞诊断率。

临床怎么用

  • 临床疑诊急性肺栓塞需胸部影像时,SPECT V/Q算法可考虑作为替代诊断路径。
  • 对SPECT V/Q阴性者,3个月VTE风险低,支持其临床管理可行性。
  • 因试验提前终止,非劣效结论未确立,应用时需结合指南与个体情况。

局限性

  • 试验因招募缓慢与经费限制于2024年10月提前终止。
  • 提前终止导致未证明SPECT V/Q策略的非劣效性。
  • 结果解释受样本量与提前终止影响,需谨慎外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Eur Respir J. 2026 Jul 23;68(1):2501742. doi: 10.1183/13993003.01742-2025. Print 2026 Jul. ABSTRACT BACKGROUND: While single-photon emission computed tomography (SPECT) ventilation/perfusion (V/Q) has been widely adopted for pulmonary embolism (PE) diagnosis, it is not currently endorsed by clinical guidelines due to insufficient evidence. METHODS: We conducted a non-inferiority randomised trial comparing SPECT V/Q-, computed tomography pulmonary angiography (CTPA)- and planar V/Q-based diagnostic strategies using a 2:1:1 allocation. The primary end-point was the 3-month risk of venous thromboembolism (VTE) in untreated patients with a negative workup, comparing SPECT V/Q to the combined CTPA and planar V/Q arms. A non-inferiority margin of 1% absolute difference in 3-month VTE risk was defined. Secondary outcomes included PE diagnosis rates. The trial ended prematurely in October 2024 due to slow recruitment and funding limitations. RESULTS: From July 2017 to October 2024, 603 patients were randomised. PE was diagnosed in 61/303 (20.1%) in the SPECT V/Q arm, 31/150 (20.7%) in the CTPA arm and 24/150 (16.0%) in the planar V/Q arm. The 3-month VTE risk in patients left untreated after a negative workup was 0.5% (1/221) for SPECT V/Q, 0.0% (0/107) for CTPA and 0.8% (1/118) for planar V/Q. The difference in outcome between SPECT V/Q and the combined arms was 0.0% (95% CI -1.2-1.3%). CONCLUSION: After being prematurely discontinued, this randomised trial did not demonstrate the non-inferiority of a SPECT V/Q-based strategy to reference standards for PE diagnosis. However, the results suggest a low 3-month VTE risk in patients managed using a SPECT V/Q-based diagnostic strategy. Among patients with clinically suspected acute PE requiring chest imaging, a SPECT V/Q-based algorithm might be a reliable alternative in clinical practice. PMID: 41927066 | PMC: PMC13392453 | DOI: 10.1183/13993003.01742-2025

来源:PubMed 高证据 · 肺栓塞,查看原文。版权归原作者所有。

引用

  1. PubMed 高证据 · 肺栓塞:Comparison of three diagnostic strategies for suspicion of pulmonary embolism: planar ventilation/perfusion scan, CT pulmonary angiography and single-photon emission CT ventilation/perfusion scan - a multicentre, non-inferiority randomised controlled trial

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。